相关实验视频

Updated: Jul 18, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

作为子宫血清癌和子宫癌瘤的分子标,HER2基因

Blair McNamara¹, Levent Mutlu¹, Michelle Greenman¹

¹Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, LSOG 305, P.O. Box 208063, New Haven, CT 06520, USA.

|August 26, 2023

概括

针对人类表皮生长因子受体2 (HER2) 的新型向疗法对于由于化疗耐药性的子宫血清癌 (USC) 和子宫癌 (UCS) 是必要的. 本综述探讨了针对这些罕见的子宫癌的HER2向剂.

科学领域:

妇科瘤学妇科瘤学
医学瘤学医学瘤学
翻译癌症研究翻译癌症研究

背景情况:

子宫血清癌 (USC) 和子宫癌 (UCS) 是罕见的子宫恶性瘤,预后不佳.
传统的基化疗效果有限,在USC和UCS患者中复发率和耐药性高.
人类表皮生长因子受体2 (HER2) 与USC和UCS有关,在显著的患者群中观察到过度表达/放大.

研究的目的:

审查目前关于针对USC和UCS的HER2向治疗方法的临床和临床前数据.
总结正在进行的临床试验,调查HER2导向疗法.
确定 HER2 向治疗策略的未来研究方向.

主要方法:

对临床前研究和临床试验进行全面的文献搜索.
对USC和UCS中的HER2表达水平数据的分析.
在妇科癌症中针对HER2的治疗策略的审查.

主要成果:

在大约30-35%的USC和15-20%的UCS中发生HER2过度表达/放大.
几种向HER2的药物正在研究中,在早期阶段的研究中显示出有希望的结果.
目前正在进行的临床试验正在评估这些新型药物的疗效和安全性.

结论:

针对HER2代表了对USC和UCS患者的一个子集的有前途的治疗途径.
进一步的研究和临床试验对于确定HER2向疗法的作用至关重要.
基于HER2状态的个性化治疗方法可能会改善这些侵袭性子宫癌的结果.

关键词:

在HER2中,HER2是HER2.抗体药物联合体癌症和肉瘤 (Carcinosarcoma) 是一种癌症.化疗化疗是一种化学疗法.这是子宫内膜癌的癌症.妇科的恶性瘤.子宫血清癌子宫血清癌

更多相关视频

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...